Assessment Of The Antifungal Bioactivity Of Aqueous Extract From Ziziphus Spina-Christi Leaves Against Candida SPP. Responsible For Vulvovaginal Candidiasis

Alyaa Hussein Talib

doi:10.61132/obat.v3i2.1107

Authors

Alyaa Hussein Talib Universitas Thiqar

DOI:

https://doi.org/10.61132/obat.v3i2.1107

Keywords:

Vulvovaginal Candidiasis (VVC), Candida spp, Antifungal, Ziziphus spina-christi leaves extract, Antimicrobial Activity

Abstract

The present study was aimed at gaining knowledge about the type of pathogen responsible for Vulvovaginal Candidiasis (VVC) infections and evaluating the antimicrobial activity of plant extracts against Candida spp. antibiotic resistance. 112 samples were taken from infected women with VVC of different ages from September to December 2024. All specimens were collected from Al Hussein Teaching Hospital/ Al- Thiqar- governorate. The results showed that 67 (59.82%) of all cases had positive results for Candida spp., while 45 (40.18%) had negative results. Candida spp. Isolated from VVC were C. albicans, the most prevalent 33 (49.26%), C. glabrata, 12 (17.91%), C. krusi and C. kefyr, 9 (13.43%), and C. guilliermondii, 4 (6.90%). The antifungal sensitivity of the pathogenic Candida spp. was tested against five types of antifungals, and the results showed the highest resistance to ketoconazole was 66 (98.51%) of Candida spp. Because of the presence of these physiologically active chemicals, Zizyphus spina-christi L. exhibits antimicrobial capabilities. In this study, the main aim is to study the antifungal activity of Ziziphus spina-christi leaf extract on some resistant candida and conduct analysis to confirm that the Ziziphus spina-christi leaves have phytochemical contents. Gas chromatography-mass spectrometry (GC-MS) was used to find the bioactive components present in extracts of Z. spina-christi leaves. Finally, we decided the inhibitory activity of Ziziphus spina-christi leaves extract. The extract of Ziziphus spina-christi had alkaloids, saponins, flavonoids, phenols, tannic acid, and terpenoids, according to a preliminary phytochemical screen. In addition, GC-MS analysis of the extract confirmed the presence of many beneficial chemicals. The extract showed promising antimicrobial activity for Candida spp. (C. albicans, C. glabrata,C. krusi , C. kefyr, and C. guilliermondii) . These results show that the Ziziphus spina-christi leaves extract is a valuable resource for bioactive chemicals with potential uses in a variety of biological contexts.

Downloads

Download data is not yet available.

References

Abalaka, M. E., Daniyan, S. Y., & Mann, A. (2010). Evaluation of the antimicrobial activities of two Ziziphus species (Ziziphus mauritiana L. and Ziziphus spinachristi L.) on some microbial pathogens. African Journal of Pharmacy and Pharmacology, 4(4), 135–139.

Brillowska-Dabrowska, A., Bergmann, O., Jensen, I. M., Jarløv, J. O., & Arendrup, M. C. (2010). Typing of Candida isolates from patients with invasive infection and concomitant colonization. Scandinavian Journal of Infectious Diseases, 42(2), 109–113.

Bukvicki, D. R., Tyagi, A. K., Gottardi, D. G., Veljic, M. M., Jankovic, S. M., Guerzoni, M. E., & Marin, P. D. (2013). Assessment of the chemical composition and in vitro antimicrobial potential of extracts of the liverwort Scapania aspera. Natural Product Communications, 8(9), 1934578X1300800932.

Ciurea, C. N., Kosovski, I.-B., Mare, A. D., Toma, F., Pintea-Simon, I. A., & Man, A. (2020). Candida and candidiasis—opportunism versus pathogenicity: a review of the virulence traits. Microorganisms, 8(6), 857.

CLSI. (2011). EP24-A2 Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves; Approved Guideline. https://clsi.org/media/1425/ep24a2_sample.pdf

De Pádua, R. F., Guilhermetti, E., & Svidzinski, T. E. (2003). In vitro activity of antifungal agents on yeasts isolated from vaginal secretion. Acta Scientiarum, 25(1), 51–54.

Deorukhkar, S. C., Saini, S., & Mathew, S. (2014). Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile. International Journal of Microbiology, 2014, 456878.

do Nascimento Dias, J., de Souza Silva, C., de Araújo, A. R., Souza, J. M. T., de Holanda Veloso Junior, P. H., Cabral, W. F., da Glória da Silva, M., Eaton, P., de Souza de Almeida Leite, J. R., & Nicola, A. M. (2020). Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. Scientific Reports, 10(1), 10327.

Emeribe, A. U., Nasir, I. A., Onyia, J., & Ifunanya, A. L. (2015). Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria. Research and Reports in Tropical Medicine, 6, 37–42.

Feglo, P. K., & Narkwa, P. (2012). Prevalence and antifungal susceptibility patterns of yeast isolates at the Komfo Anokye Teaching Hospital (KATH), Kumasi, Ghana. British Microbiology Research Journal, 2(1), 10–22.

Fournier, F., & Mendling, J. (2015). Business Process Management Workshops: BPM 2014 International Workshops, Eindhoven, the Netherlands, September 7-8, 2014, Revised Papers (Vol. 202). Springer.

Ghorai, N., Chakraborty, S., Gucchait, S., Saha, S. K., & Biswas, S. (2012). Estimation of total Terpenoids concentration in plant tissues using a monoterpene, Linalool as standard reagent.

Golla Eshwara Chandra, Goteti Venkata Padmaja, C. R. H. (2023). Isolation, Speciation of Candida Species By Candida Differential Agar And Antifungal Susceptibility From Various Clinical Samples In Tertiary Care Hospital, Warangal. Global Journal For Research Analysis, 12(12), 5–7. https://doi.org/10.36106/gjra/8600259

Gonçalves, B., Ferreira, C., Alves, C. T., Henriques, M., Azeredo, J., & Silva, S. (2016). Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Critical Reviews in Microbiology, 42(6), 905–927.

Hedayati, M. T., Taheri, Z., Galinimoghadam, T., Aghili, S. R., Cherati, J. Y., & Mosayebi, E. (2015). Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur Journal of Microbiology, 8(4).

Kamya Ramesh Swaminathan, D. M. D., Gerald, S., & Swathi, C. (2017). Prevalence of vulvovaginal candidiasis in the women of the reproductive age, in rural India. Diabetes, 7, 5–8.

Khandelwal, N. K., Wasi, M., Nair, R., Gupta, M., Kumar, M., Mondal, A. K., Gaur, N. A., & Prasad, R. (2019). Vacuolar sequestration of azoles, a novel strategy of azole antifungal resistance conserved across pathogenic and nonpathogenic yeast. Antimicrobial Agents and Chemotherapy, 63(3), 10–1128.

Laouini, S. E., & Ouahrani, M. R. (2017). Phytochemical screening, in vitro antioxidant and antibacterial activity of Rumex vesicarius L. extract. Scientific Study & Research. Chemistry & Chemical Engineering, Biotechnology, Food Industry, 18(4), 367–376.

Midhat, et al. (2020). Balance in health-related quality of life among young adolescent cancer survivors. University of Houston.

Mukherjee, K., Tribedi, P., Mukhopadhyay, B., & Sil, A. K. (2013). Antibacterial activity of long-chain fatty alcohols against mycobacteria. FEMS Microbiology Letters, 338(2), 177–183.

Perfect, J. R., & Ghannoum, M. (2020). Emerging issues in antifungal resistance. Infectious Disease Clinics, 34(4), 921–943.

Pfaller, M. A., Castanheira, M., Messer, S. A., Moet, G. J., & Jones, R. N. (2010). Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009). Diagnostic Microbiology and Infectious Disease, 68(3), 278–283.

Ramírez-Lozada, T., Espinosa-Hernández, V. M., Frías-De-León, M. G., & Martínez-Herrera, E. (2019). Update of vulvovaginal candidiasis in pregnant and non-pregnant patients. Current Fungal Infection Reports, 13, 181–190.

Rati, R., Patel, J., & Rishi, S. (2015). Vulvovaginal candidiasis and its antifungal susceptibility pattern: single center experience. International Journal of Medical Research and Review, 3(1), 72–78.

Rós Ásmundsdóttir, L., Erlendsdóttir, H., Haraldsson, G., Guo, H., Xu, J., & Gottfredsson, M. (2008). Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clinical Infectious Diseases, 47(2), e17–e24.

Sobel, J. D., & Chaim, W. (1997). Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clinical Infectious Diseases, 24(4), 649–652.

Vandeputte, P., Ferrari, S., & Coste, A. T. (2012). Antifungal resistance and new strategies to control fungal infections. International Journal of Microbiology, 2012, 713687.

Willems, H. M. E., Ahmed, S. S., Liu, J., Xu, Z., & Peters, B. M. (2020). Vulvovaginal candidiasis: a current understanding and burning questions. Journal of Fungi, 6(1), 27.

Yahia, Y., Benabderrahim, M. A., Tlili, N., Bagues, M., & Nagaz, K. (2020). Bioactive compounds, antioxidant and antimicrobial activities of extracts from different plant parts of two Ziziphus Mill. species. PloS One, 15(5), e0232599.

Yang, W., Chen, X., Li, Y., Guo, S., Wang, Z., & Yu, X. (2020). Advances in pharmacological activities of terpenoids. Natural Product Communications, 15(3), 1934578X20903555.

Yano, Y., Reis, J. P., Colangelo, L. A., Shimbo, D., Viera, A. J., Allen, N. B., Gidding, S. S., Bress, A. P., Greenland, P., & Muntner, P. (2018). Association of blood pressure classification in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline with cardiovascular events later in life. Jama, 320(17), 1774–1782.